<DOC>
	<DOCNO>NCT00845416</DOCNO>
	<brief_summary>The goal propose research establish validity newborn screen method severe combine immunodeficiency ( SCID ) . The assay use developed basis PCR quantification T-cell receptor excision circle ( TRECs ) absent SCID patient , thus correlate disease</brief_summary>
	<brief_title>Newborn Screening Severe Combined Immunodeficiency ( SCID ) High-Risk Population</brief_title>
	<detailed_description>To show early diagnosis SCID TREC screen assay warrant timely treatment disease avoid life-threatening infection patient . Babies SCID unable fight infection . They become severely ill first month life survive unless immune system restore . SCID treat bone marrow transplant recognize early . The newborn screen test employ study design diagnose SCID infection occur . By conduct pilot test program high-risk population Navajo Indian Reservation , one 2,000 infant born SCID , hope confirm benefit newborn screen early diagnosis SCID</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Severe Combined Immunodeficiency</mesh_term>
	<mesh_term>Lymphopenia</mesh_term>
	<criteria>Birth study hospital Navajo Reservation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Days</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>TREC</keyword>
	<keyword>T cell</keyword>
	<keyword>Primary Immunodeficiency</keyword>
	<keyword>PID</keyword>
	<keyword>Navajo</keyword>
	<keyword>SCID</keyword>
</DOC>